USPTO serial 79347658
NOVODIAG
Reviewed by CopyMark Law Group
Reg. 7109889Status 404
- Filing date
- Status date
- Registration date
- Jul 18, 2023
- Examiner
- SINGH, DEEP K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NOVODIAG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles F. Reidelbach Jr.
Charles F. Reidelbach Jr. Higgs Fletcher & Mack LLP401 West A Street, Suite 2600San Diego, CA 92101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents for scientific or research use; diagnostic reagents, other than for medical use, for sale in kit form comprised of reagents for detecting nucleic acids or other biological markers; diagnostic reagents for in-vitro use other than for medical purposes; diagnostic preparations or reagents for scientific or research use | SECTION 70 - CANCELLED | — |
| 005 | Reagents for use in diagnostic tests for medical purposes | SECTION 70 - CANCELLED | — |
| 009 | Analyzer software for in-vitro diagnostic purposes, namely, downloaded computer software for analysis of in-vitro diagnostic tests | SECTION 70 - CANCELLED | — |
| 010 | Medical diagnostic instruments, namely, instruments for use in in-vitro diagnostics or for detecting nucleic acids or other biological markers; medical analysis instruments, namely, for use in in-vitro diagnostics or for detecting nucleic acids or other biological markers; medical testing instruments, namely, for detecting infectious diseases; medical diagnostic apparatus, namely, in-vitro test kits comprised of reagents for detecting nucleic acids or other biological markers | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mobidiag Oy
- Other trademarks owned by Mobidiag Oy
- Other trademarks owned by Mobidiag Oy
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named NOVODIAG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 2, 2026 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 2, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 13, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 19, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 19, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 18, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 18, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 18, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 17, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 2, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 2, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 26, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 26, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 12, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 6, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Feb 9, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 14, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 13, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 8, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 18, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |